Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis bcl 2 family'

Search results for: 'research area apoptosis bcl 2 family'

Items 11-20 of 47

Page
per page
  1. PCI-24781 (CRA-024781)
    A4098 PCI-24781 (CRA-024781)
    Target: Histone Deacetylases (HDACs)
    Summary: Pan-HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥11.75 mg/mL
  2. CI994 (Tacedinaline)
    A4102 CI994 (Tacedinaline)
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥50 mg/mL
  3. GSK1070916
    A4127 GSK1070916
    Target: Aurora Kinases
    Summary: Aurora B/C inhibitor
      ≥25.4 mg/mL
  4. Bromosporine
    A4186 Bromosporine
     1 Citation
    Target: Bromodomains
    Summary: Bromodomain inhibitor,non-selective
      ≥40.4 mg/mL
  5. 5-Azacytidine
    A1907 5-Azacytidine
     6 Citation
    Target: DNA Methyltransferases
    Summary: DNA methyltransferase inhibitor.
      insoluble in EtOH; ≥24.45 mg/mL
  6. Sephin1
    A8708 Sephin1
     1 Citation
    Target: phosphatases
    Summary: Selective PPP1R15A inhibitor
      insoluble in H2O; insoluble in EtOH; ≥7.75 mg/mL
  7. Chidamide
    B5916 Chidamide
     1 Citation
    Target: HDAC
    Summary: Novel HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥18.55 mg/mL
  8. HPOB
    B4890 HPOB
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor, potent and selective
      ≥31.4 mg/mL
  9. MK-4827
    A3617 MK-4827
    Target: PARP
    Summary: PARP-1/-2 inhibitor,potent and selective
      ≥32 mg/mL
  10. OTX-015
    A3692 OTX-015
     3 Citation
    Target: Bromodomains
    Summary: BRD inhibitor
      ≥24.6 mg/mL

Items 11-20 of 47

Page
per page
Shop By
Now Shopping by
  1. Category Chromatin/Epigenetics Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Bromodomain 4item
  2. Aurora Kinase 6item
  3. DNA Methyltransferase 2item
  4. HDAC 13item
  5. Histone Demethylases 1 item
  6. Histone Methyltransferase 3item
  7. JAK 10item
  8. PARP 5item
  9. Pim 1 item
  10. Protein Ser/Thr Phosphatases 1 item
  11. Sirtuin 1 item
  12. Sphingosine Kinase-2 1 item
Specificity
  1. Selective 32item
Reversibility
  1. Reversible 2item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 11item
  3. PI3K 1 item
  4. Aurora Kinases 6item
  5. EZH2 1 item
  6. Bromodomains 4item
  7. FLT3 1 item
  8. PLK 1 item
  9. DOT1L 1 item
  10. FGFR 1 item
  11. Pim 1 item
  12. Sir2-like Family Deacetylases (Sirtuins) 1 item
  13. STAT 2item
  14. JAK 10item
  15. EZH1 1 item
  16. TNKS 1 item
  17. DNA Methyltransferases 2item
  18. PARP 4item
  19. phosphatases 1 item
  20. MNK 1 item
  21. Cytidine deaminases 1 item
  22. c-RET 1 item
  23. p53 1 item
  24. HDAC 1 item
  25. p21 1 item
  26. SK 1 item
Related Disease
  1. Acute Myeloid Leukemia 3item
  2. Bladder Carcinoma 1 item
  3. Breast Cancer 9item
  4. Cancer 31item
  5. Castration-resistant Prostate Cancer 1 item
  6. Cervical Cancer 2item
  7. Colon Cancer 5item
  8. Colon Carcinoma 1 item
  9. Colorectal Cancer 1 item
  10. Diffuse Large B-cell Lymphoma 1 item
  11. Glioblastoma 1 item
  12. Glioma 2item
  13. Hepatocellular Carcinoma 1 item
  14. HIV 2item
  15. HIV Infections 1 item
  16. Immunological Diseases 1 item
  17. Inflammatory Bowel Disease 1 item
  18. Inflammatory Diseases 2item
  19. Leukemia 3item
  20. Lung Cancer 3item
  21. Mixed Lineage Leukemia 1 item
  22. Multiple Myeloma 3item
  23. Myelofibrosis 1 item
  24. Myeloma 1 item
  25. Non-small Cell Lung Cancer 3item
  26. Ovarian Cancer 1 item
  27. Pancreatic Cancer 2item
  28. Prostate Cancer 5item
  29. Psoriasis 1 item
  30. Renal Cell Carcinoma 1 item
  31. Rheumatoid Arthritis 3item